Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(25%)

    Phase Distribution

    Not Applicable
    1
    25%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    N/ANon-phased studies
    1(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    4

    all time

    Status Distribution
    Active(2)
    Other(2)

    Detailed Status

    unknown2
    Recruiting1
    Not yet recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    4
    Active
    1
    Success Rate
    N/A
    Most Advanced
    N/A

    Trials by Phase

    N/A1 (100.0%)

    Trials by Status

    recruiting125%
    not_yet_recruiting125%
    unknown250%

    Recent Activity

    1 active trials
    Showing 4 of 4
    not_yet_recruiting

    Mechanistic 129 Xe MRI Study to Assess Therapeutic Response in Fibrotic Interstitial Lung Disease

    NCT07786090
    recruiting

    PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)

    NCT07143747
    unknownnot_applicable

    Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease

    NCT03455686
    unknown

    Ventilation Heterogeneity Prior to Lung Resection

    NCT04191174

    Clinical Trials (4)

    Showing 4 of 4 trials
    NCT07786090

    Mechanistic 129 Xe MRI Study to Assess Therapeutic Response in Fibrotic Interstitial Lung Disease

    Not Yet Recruiting
    NCT07143747

    PAXT: Pulmonary Imaging of Mild Asthma Using 129Xe MRI and Tc-99-Labeled-Carbon-Imaging (Tc99CImaging)

    Recruiting
    NCT03455686Not Applicable

    Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease

    Unknown
    NCT04191174

    Ventilation Heterogeneity Prior to Lung Resection

    Unknown

    All 4 trials loaded

    Drug Details

    Intervention Type
    Other
    Total Trials
    4